OCT 27, 2026 · JOURNAL ARTICLE
HER2 in mullerian malignancies: diagnostic challenges and the emerging HER2-low paradigm
Obstetrics & Gynecology Science
The role of human epidermal growth factor receptor 2 (HER2) in gynecological oncology has evolved from a histotype-restricted biomarker to a central component of molecular stratifi